Sub-20 nm LiErF4-Based Upconversion Nanophosphors for Simultaneous Imaging and Photothermal Therapeutics

Title
Sub-20 nm LiErF4-Based Upconversion Nanophosphors for Simultaneous Imaging and Photothermal Therapeutics
Authors
변지영장호성홍아라이광렬
Keywords
upconversion; nanophosphor; core/multishell; photothermal property
Issue Date
2020-09
Publisher
ACS applied nano materials
Citation
VOL 3, NO 9-8671
Abstract
This study reports red-emitting LiErF4:Tm-based upconversion nanophosphors (UCNPs) with small size and high brightness for simultaneous upconversion luminescence (UCL) imaging and photothermal therapeutics. Strong red UCL is realized from LiErF4-based UCNPs by doping Tm3+ into LiErF4 and forming multishells on the LiErF4:Tm core. The ultrasmall LiErF4:Tm UCNPs are facilely synthesized by using rare-earth-oleate precursors and a mixed solvent of oleic acid and 1-octadecene. The size of the ultrasmall LiErF4:Tm(0.3%) UCNPs is finely tuned from 2.8 to 10.4 nm, and LiErF4:Tm(0.3%)/LiGdF4 core/shell (C/S) UCNPs show small sizes ranging from 8.6 to 13.2 nm. Notably, 11.4 nm-sized C/S UCNPs show bright red light. Furthermore, LiErF4:Tm-based core/triple-shell (C/T-S) UCNPs are synthesized, and they show dramatic enhancement of red UCL (∼4242-fold enhancement compared with the core under 980 nm excitation and ∼89-fold and ∼14-fold enhancement compared with the C/S UCNPs under 800 and 1532 nm excitation, respectively). Besides UCL enhancement, Nd3+ ions doped in the LiErF4:Tm-based C/T-S UCNPs generate heat under 800 nm irradiation, allowing the C/T-S UCNPs to be applied as photothermal therapeutic agents. The ultrasmall (<20 nm) and bright red-emitting LiErF4:Tm-based C/T-S UCNPs have the potential for simultaneous imaging and photothermal therapeutic applications.
URI
http://pubs.kist.re.kr/handle/201004/72314
ISSN
2574-0970
Appears in Collections:
KIST Publication > Article
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE